Pirfenax (Pirfenax)200 MG – 30 tablet

$28.82

Each Pirfenax contains 200 mg Pirfenidone 30 tablets used to treat idiopathic pulmonary fibrosis, a progressive lung disease.

ATC Classification: L04AX05
Active Ingrediant: Pirfenidone
Generic Name: Pirfenax
Manufacturer: Cipla Limited
Strength: 200 MG
Dosage Type: Tablet CR
Packaging Type: Foil in Box
Contains: 30 Tabs

 

Storage/Stability

Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F).

 

Adverse Reactions

>10%:

Central nervous system: Fatigue (26%), headache (22%), dizziness (18%)

Dermatologic: Skin rash (30%)

Gastrointestinal: Nausea (36%), diarrhea (26%), abdominal pain (24%), dyspepsia (19%), anorexia (13%), vomiting (13%), gastroesophageal reflux disease (11%)

Respiratory: Upper respiratory tract infection (27%), sinusitis (11%)

1% to 10%:

Central nervous system: Insomnia (10%), noncardiac chest pain (5%)

Dermatologic: Skin photosensitivity (9%), pruritus (8%)

Endocrine & metabolic: Weight loss (10%)

Gastrointestinal: Decreased appetite (8%), dysgeusia (6%)

Hepatic: Increased serum transaminases (ALT and AST; ≥3 x ULN: 4%)

Neuromuscular & skeletal: Arthralgia (10%), asthenia (6%)

Postmarketing: Agranulocytosis, angioedema, hepatotoxicity

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , ,

Strength

Dosage Type

Packaging Type

Brand

Cipla

Reviews

There are no reviews yet.

Be the first to review “Pirfenax (Pirfenax)200 MG – 30 tablet”

Your email address will not be published. Required fields are marked *